New formulation of prostate drug put to the test in healthy volunteers
Knowledge-focused
Recruiting now
This study compares a new formulation (AJU-G721) of a drug used for benign prostatic hyperplasia (BPH) to the original version (G721R) in healthy adult men. The goal is to see if the two versions are absorbed and processed by the body in the same way. Participants receive a singl…
Phase: PHASE1 • Sponsor: AJU Pharm Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC